Monsanto Co (MON.N)
LEVERKUSEN, Germany German drugs and pesticides maker Bayer forecast a year without earnings growth for its agricultural products business on Wednesday, as it seeks to complete its $66 billion deal to take over U.S. seeds giant Monsanto .
FRANKFURT, Feb 22 Bayer, the German drugmaker that is buying U.S. seed maker Monsanto, said it expected a mid-single digit percentage increase in adjusted core earnings for 2017, helped by fast growing revenues from stroke prevention pill Xarelto.
FRANKFURT, Feb 21 Germany's largest drugmaker Bayer said on Tuesday it would propose an annual dividend of 2.70 euros per share to investors, in line with analysts' expectations and up from 2.50 euros a year earlier.
* Berkshire Hathaway Inc takes share stake of 8 million shares in Monsanto Co - SEC filing
California can force Monsanto Co to label its widely used weed killer Roundup as a possible cancer-causing substance, a state judge ruled on Friday.
MEXICO CITY A ban on planting genetically modified corn in Mexico is likely to continue for years as a slow-moving legal battle grinds on, said a top executive of U.S.-based seed and agrochemical company Monsanto Co.
MEXICO CITY, Jan 30 A ban on planting genetically modified corn in Mexico is likely to continue for years as a slow-moving legal battle grinds on, said a top executive of U.S.-based seed and agrochemical company Monsanto Co.
* Shareowners did not approve shareowner proposal presented at meeting requesting a Glyphosate report Source text: [http://bit.ly/2jyfVa1] Further company coverage:
* Monsanto board approves dividend of 54 cents per share Source text for Eikon: Further company coverage:
(The following statement was released by the rating agency) NEW YORK, January 24 (Fitch) Fitch Ratings has maintained Monsanto Company's (Monsanto) 'A-' Long-Term Issuer Default Rating (IDR) on Rating Watch Negative. A full list of ratings follows at the end of this release. On Sept. 14, 2016, Bayer announced that it had signed a definitive agreement to acquire Monsanto for a revised $66 billion acquisition price including assumed debt ($8.6 billion as of Nov. 30, 2016). The Negative Watch
|BASF SE (BASFn.DE)||€87.70||+0.34|
|Dow Chemical Co (DOW.N)||$63.10||-0.45|
|E I Du Pont De Nemours And Co (DD.N)||$79.42||-0.39|
|E I Du Pont De Nemours And Co (DD_pa.N)||$87.50||--|
|E I Du Pont De Nemours And Co (DD_pb.N)||$101.79||--|
|Bayer AG (BAYGn.DE)||€104.30||+0.05|
|Bayer AG (BAYE.F)||--||--|
|Syngenta AG (SYNN.S)||CHF430.10||+2.00|